SCHEMBL7188525

SCHEMBL7188525

CCCCCCP(=O)(C(=O)c1c(C)cc(C(C)(C)C)cc1C)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CETP P11597 6/20 0.42
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37
ALDH1A1 P00352 3/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 2/20 0.36
ALPG P10696 1/20 0.36
ALOX12 P18054 1/20 0.36
NPY1R P25929 1/20 0.36
HTT P42858 1/20 0.36
NPY2R P49146 1/20 0.36
NAAA Q02083 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
PKM P14618 1/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MMP1 P03956 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7189024 1.00 CETP (0.42) CETPHDAC3HDAC1HDAC2NPSR1
SCHEMBL7179947 1.00 CETP (0.42) CETPHDAC3HDAC1HDAC2NPSR1
SCHEMBL7181959 1.00 CETP (0.42) CETPHDAC3HDAC1HDAC2NPSR1
SCHEMBL7177648 0.99 CETP (0.40) CETPHDAC3HDAC1HDAC2NPSR1
SCHEMBL7180844 0.95 TSHR (0.39) CETPHDAC3HDAC1HDAC2NPSR1
SCHEMBL7179807 0.90 LMNA (0.39) ALDH1A1GAAMAPTMEN1KMT2A
SCHEMBL7187160 0.88 CETP (0.45) CETPNPSR1ALDH1A1GAAMAPT
SCHEMBL7178304 0.88 CETP (0.45) CETPNPSR1ALDH1A1GAAMAPT
SCHEMBL7186592 0.88 CETP (0.45) CETPNPSR1ALDH1A1GAAMAPT
SCHEMBL7189114 0.88 CETP (0.45) CETPNPSR1ALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 CETP 750/4885HDAC3 562/4885HDAC1 1556/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 CETP 526/4885HDAC3 406/4885HDAC1 1870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.